INO. PR. recovery & candle.
WASHINGTON and BLUE BELL, Pa. , Jan. 7, 2013 /PRNewswire/ -- The PATH Malaria Vaccine Initiative (MVI) and Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced a follow-on collaboration to advance malaria vaccine development and new vaccination delivery technologies.
(0)
(0)(0)(0)
(0)(0)(0)(0)